Restrictive cardiomyopathy secondary to hydroxychloroquine therapy

J Rheumatol. 2009 Feb;36(2):440-1. doi: 10.3899/jrheum.080305.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antirheumatic Agents / adverse effects
  • Cardiomyopathy, Restrictive / chemically induced*
  • Cardiomyopathy, Restrictive / diagnostic imaging
  • Cardiomyopathy, Restrictive / pathology*
  • Echocardiography
  • Female
  • Heart / drug effects*
  • Humans
  • Hydroxychloroquine / adverse effects*
  • Hypertrophy, Left Ventricular / chemically induced
  • Hypertrophy, Left Ventricular / pathology
  • Iatrogenic Disease / prevention & control
  • Inclusion Bodies / drug effects
  • Inclusion Bodies / pathology
  • Inclusion Bodies / ultrastructure
  • Lupus Erythematosus, Systemic / drug therapy*
  • Microscopy, Electron, Transmission
  • Middle Aged
  • Myocardium / pathology*
  • Myocardium / ultrastructure
  • Sarcoplasmic Reticulum / drug effects
  • Sarcoplasmic Reticulum / pathology

Substances

  • Antirheumatic Agents
  • Hydroxychloroquine